• 1
    Cohen MS, Chen YQ, McCauley Met al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493505.
  • 2
    Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; 1: CD003255.
  • 3
    Quinn TC, Wawer MJ, Sewankambo Net al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921929.
  • 4
    Hughes JP, Baeten JM, Lingappa JRet al. for the Partners in Prevention HSV/HIV Transmission Study Team. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012; 205: 358365.
  • 5
    Centers for Disease Control and Prevention. HIV transmission risk. 2012. Available at (accessed 10 January 2013).
  • 6
    Gray RH, Wawer MJ. Probability of heterosexual HIV-1 transmission per coital act in sub-Saharan Africa. J Infect Dis 2012; 205: 351352.
  • 7
    Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010; 39: 10481063.
  • 8
    Fisher M, Pao D, Brown AEet al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 2010; 24: 17391747.
  • 9
    PARTNER study, Copenhagen HIV programme. Available at (accessed 10 January 2013).
  • 10
    Else LJ, Taylor S, Back DJ, Khoo SH. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir Ther 2011; 16: 11491167.
  • 11
    Street E, Curtis H, Sabin CA, Monteiro EF, Johnson MA, for the British HIV Association (BHIVA) and BHIVA Audit and Standards Subcommittee. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve. HIV Med 2009; 10: 337342.
  • 12
    Hayes R, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit J. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS 2010; 24 (Suppl 4): S15S26.
  • 13
    Tanton C, Weiss HA, Rusizoka Met al. Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis 2010; 201: 12851297.